Rabe KF, Pavord ID, Busse WW, Chupp GL, et al. Dupilumab Improves Long-term Outcomes in Patients With Uncontrolled, Moderate-to-Severe GINA-Based Type 2 Asthma, Irrespective of Allergic Status. Allergy 2023 Apr 19. doi: 10.1111/all.15747.
PMID: 37073882